Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 10, 2018 (8 years ago)

Alprostadil 500 mcg/mL Injectable

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Incorrect Product Formulation

Cause type: Other

Recalls whose stated reason does not fall into the categories above. See the recall's own reason text for the specifics. All other recalls.

What was recalled

Alprostadil 500 mcg/mL Injectable, Vials, Westlab Pharmacy, Inc., Gainesville, FL 32607 NDC 10002-7335-00

Affected NDC 10002-7335-00

Compare with the code on your package — it is the most precise check available.

Drug: Alprostadil

Recalling firm
Westlab Pharmacy, Inc. dba Westlab Pharmacy
NDC code
10002-7335-00
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0089-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Alprostadil recalls

See all
Class III · Low risk

Alprostadil Injection USP 500 mcg/mL

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

Terminated Impurity / degradation Teva Pharmaceuticals USA Inc NDC 0703-1501-02 D-0988-2022

Other recalls by Westlab Pharmacy, Inc. dba Westlab Pharmacy

All 2018 recalls
Class II · Moderate risk

ADAA Cataract Drops

Lack of Process Controls

Terminated cGMP deviation Westlab Pharmacy, Inc. dba Westlab Pharmacy NDC 10002-2579-05 D-0090-2019